A prominent role for TGF-␤1 in the homeostatic regulation of the immune system was suggested by the phenotype of TGF-␤1 Ϫ/Ϫ mice. These mice develop a rapid wasting syndrome, which leads to death at the age of 3-4 wk (1). The autoimmune phenotype of TGF-␤1 Ϫ/Ϫ mice has been largely ascribed to the presence of activated CD4 ϩ T cells (2) . However, the precise mechanism of spontaneous T cell activation in the absence of TGF-␤1 remains to be elucidated. To analyze the specific effects of TGF-␤ on T cells, we and others previously created transgenic (TG) 4 mouse models with an impaired TGF-␤ signaling pathway in T cells by overexpressing a truncated version of the TGF-␤ type II receptor (⌬uT␤RII) under control of T cell-specific promoters (3) (4) (5) . In one of these models, an autoimmune-like phenotype was observed, although these mice survived at least until 3-4 mo of age without developing overt disease (4) . The TG mice generated in our group did not develop any spontaneous autoimmune disease, but showed an increased susceptibility to the induction of allergic and autoimmune diseases (3, 6, 7) .
Regulatory T cells (Treg) have been defined, for the lack of a more specific marker, as small CD4 ϩ CD25 ϩ T cells. The presence of these cells has been shown to be essential for the control of various autoreactive T cell responses (8) . Ablating the generation of Treg by neonatal thymectomy on day 3 led to the development of autoimmune disease, suggesting the thymus as the site of CD4 ϩ CD25 ϩ Treg generation (9) . Recent evidence suggests that CD4 ϩ
CD25
ϩ Treg may also be induced in the periphery (10) . Of note, TGF-␤ has been implicated in the conversion of naive CD4 ϩ CD25 Ϫ T cells into CD4 ϩ CD25 ϩ T cells by the induction of Foxp3 (11, 12) . However, it was reported that in TGF-␤1 Ϫ/Ϫ mice, CD4 ϩ CD25 ϩ Treg were able to develop up to an age of 2 wk and that autocrine TGF-␤1 production was not essential for these cells to exhibit suppressive activity in vivo (13) . Furthermore, because of the rapid onset of inflammation in TGF-␤1 Ϫ/Ϫ mice (1), it is difficult to study the development of Treg function over time.
Several experimental colitis models have been developed to enhance our understanding of mucosal immune regulation (14, 15) . In dextran sulfate sodium (DSS)-induced colitis, mice ingest DSS for 6 -10 days and develop an acute colitis that is characterized by diarrhea, gross rectal bleeding, and weight loss. Histologically, the model resembles some features of ulcerative colitis. Macrophages and neutrophils have been identified as the main effector cells of acute DSS colitis (16) .
The data presented demonstrate that TGF-␤ promotes the in vivo expansion and suppressive function of CD4 ϩ CD25 ϩ Treg. These findings indicate that the impairment of TGF-␤ signaling in CD4 ϩ CD25 ϩ Treg might contribute to the increased susceptibility to autoimmune disease found in hCD2-⌬kT␤RII mice.
Materials and Methods

Animals
The generation and characterization of TG hCD2-⌬kT␤ RII mice is described elsewhere (3). All TG lines were established and maintained as heterozygotes on a FVB/N background. For colitis induction, age-and sex-matched mice between 8 and 10 wk of age were used. Age-matched nontransgenic littermates were used as controls. Animal care was in accordance with the governmental and institutional guidelines.
Induction of DSS colitis
DSS (ICN Biochemicals, Cleveland, OH) with a molecular weight of 36 -40 kDa was dissolved in deionized autoclaved water to provide a working solution of 2.25 or 3% (w/v). Mice were given free access to water substituted with DSS for 9 days.
Collection of colonic tissue
A 0.75-cm segment from the distal colon was removed and embedded in paraffin. Five-micrometer sections were stained with H&E.
Histological and endoscopic scoring
Histological scoring was performed by a pathologist in a blinded fashion as described before (17). The experimental setup for endoscopic scoring consisted of a miniendoscope, a light source, and an air pump to inflate the mouse colon. Scoring was performed in a blinded fashion, giving 0 -3 points for vascularity, translucency, and stool.
Lymphocyte separation and adoptive cell transfer
CD25
ϩ lymphocytes from spleens of 7-to 9-wk-old mice were separated with MACS beads. In a second step, CD4
ϩ CD25 ϩ cells were sorted with a FACSVantage cell sorter (BD Biosciences, Heidelberg, Germany). Purity of cell separation ranged around 95% as assessed by flow cytometry. For some experiments, 7.5 ϫ 10 5 CD4 ϩ CD25 ϩ or CD4 ϩ CD25 Ϫ T cells were injected i.p. 8 h before colitis induction. For CFSE labeling, cells were incubated in 2 M CFSE (Molecular Probes, Leiden, The Netherlands) in PBS at 37°C for 10 min. Isolation of lamina propria mononuclear (LPMN) cells was performed essentially as described previously (14) .
Flow cytometry
For flow cytometric analysis, cells were stained with CD25-PE (Miltenyi Biotec, Auburn, CA) and CD4-PE-Cy7 (Caltag Laboratories, Burlingame, CA). Flow cytometry was performed with a FACSCalibur using CellQuest software (BD Biosciences). At least 1 ϫ 10 6 cells were analyzed. 
Cell culture and cell proliferation assays
Cell culture was performed essentially as described elsewhere (3). Supernatants were collected after 60 h and frozen in liquid nitrogen. Suppressor assays were performed essentially as described previously (18).
Cytokine assays
Concentrations of IFN-␥, IL-5, IL-6, IL-10 (Mouse BD OptEIA ELISA Sets; BD Pharmingen, San Diego, CA), and TNF-␣ (R&D Systems, Minneapolis, MN) in cell culture supernatants were measured according to the manufacturer's instructions. 
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Statistical analysis
Mean Ϯ SEM are given. For the comparison of groups, the two-sided Wilcoxon rank sum test was applied and a p Ͻ 0.05 was considered to be significant. Experiments were repeated at least twice with similar results. 
Results
CD4
CD25
ϩ Treg mediated a significant protection from colitis, which was characterized by a reduced weight loss and a lower endoscopic and histological colitis score (Fig. 1,A-D) . In contrast, CD4 ϩ CD25 ϩ Treg isolated from hCD2-⌬kT␤RII mice lacked a protective effect (Fig. 1, A-D 
ϩ Treg (Fig. 1E) , underlining that the in vitro suppressor assays do not adequately reflect the in vivo situation. 
ϩ CFSE ϩ cells remained undivided (Fig. 2,A and C) . The CFSE ϩ cells were confirmed to be CD4 ϩ and CD25 ϩ by flow cytometry (Fig. 2B) . Upon transfer of CFSE ϩ CD4 ϩ CD25 ϩ cells into healthy WT mice or immunodeficient SCID mice, no difference in proliferation was observed between TG and WT CD4 ϩ CD25 ϩ Treg until day 4 after transfer ( Fig. 2D) . In vitro, TGF-␤ alone or in combination with IL-2 was not sufficient to induce proliferation of CD4 ϩ
ϩ T cells (Fig. 2E  and data not shown) . These results demonstrate that endogenous TGF-␤ significantly contributes to the expansion of CD4 ϩ CD25 ϩ Treg in vivo, but indicates the involvement of other mediators of inflammation yet to be identified.
Adult hCD2-⌬kT␤RII mice develop decreased numbers of peripheral
Since the expansion of CD4 ϩ CD25 ϩ Treg was reduced upon transfer and colitis induction, we aimed to analyze CD4 ϩ CD25 ϩ Treg numbers in hCD2-⌬kT␤RII TG mice.
No difference was observed in thymic CD4
ϩ CD8 Ϫ CD25 ϩ T cell numbers between TG and WT mice of various ages (Fig.  3A) . In peripheral lymphoid organs of BALB/c mice, the numbers of CD4 ϩ CD25 ϩ Treg seem to be maintained from an age of 2 wk onward (22). Accordingly, in FVB/N WT mice between 3 and 7 wk of age, the numbers of peripheral CD4 ϩ CD25 ϩ Treg were relatively stable (Fig. 3B) . However, in TG mice the numbers of CD4 ϩ CD25 ϩ Treg decreased between the age of 4 -6 wk, but remained stable thereafter (Fig. 3B) .
The susceptibility to the induction of colitis is increased in hCD2-⌬kT␤RII mice and can be completely reversed by the transfer of WT
To support a role for endogenous TGF-␤ for the functional development of CD4 ϩ CD25 ϩ Treg in vivo, an acute colitis was induced in hCD2-⌬kT␤RII mice by feeding 2.25% DSS in drinking water over a period of 9 days. TG mice developed a severe colitis, whereas WT mice developed only a mild colitis at this concentration of DSS (Fig. 4,A-C) . Furthermore, mononuclear cells isolated from the lamina propria of TG coli showed an increased cytokine production, mainly of IL-6, IL-10, and IFN-␥ as compared with WT (Fig. 4D) .
Since the number and the functional capacity of TG CD4 ϩ CD25 ϩ Treg was reduced, we tested whether the transfer of WT CD4 ϩ
CD25
ϩ Treg into TG mice was able to ameliorate colitis. The increased susceptibility of TG mice could be completely reversed by the transfer of WT CD4 ϩ CD25 ϩ Treg 8 h before colitis induction (Fig. 4, A-C) . The increased cytokine production of TG LPMN cells was markedly reduced by the transfer of CD4 ϩ CD25 ϩ Treg, although not reaching WT levels (Fig. 4D) . In contrast, no protection was seen after the transfer of CD4 ϩ CD25 Ϫ T cells (data not shown). ϩ CD8 Ϫ cells were gated. There was no difference in the total cell numbers between WT and TG mice. At least nine littermates were analyzed at each time point ‫,ء(‬ p Ͻ 0.03).
Discussion
Data regarding the role of TGF-␤ for the in vivo function of CD4 ϩ
CD25
ϩ Treg are controversial. Whereas it was reported that CD4 ϩ CD25 ϩ Treg isolated from TGF-␤1 Ϫ/Ϫ mice do not protect recipient mice from colitis in the SCID transfer colitis model (20) and that the suppression of islet-specific CD8 ϩ T cells by CD4 ϩ CD25 ϩ Treg is mediated by TGF-␤ (21), it was also reported that TGF-␤1 expression is not essential for the in vivo function of CD4 ϩ CD25 ϩ Treg (13) . In the colitis model described, TGF-␤ signaling in effector T cells was not essential for suppression mediated by CD4 ϩ CD25 ϩ Treg. However, significant differences exist in the TG mice, disease models, and the population of effector cells analyzed. In other experiments, the suppression of inflammation mediated by CD4 ϩ
ϩ Treg could be abrogated by injecting neutralizing TGF-␤ Ab (23-26).
However, from the experiments using TGF␤1 Ϫ/Ϫ mice or anti-TGF-␤ treatment, it remains unclear whether TGF-␤ is required as an effector cytokine or whether CD4 
ϩ Treg, is modulated by TGF-␤ in vitro (11, 12) and in vivo (18). Therefore, Foxp3 might mediate some of the effects induced by TGF-␤.
It was recently reported that TGF-␤1 Ϫ/Ϫ mice have normal numbers of CD4 ϩ
ϩ Treg after birth, indicating that CD4 ϩ CD25 ϩ Treg are able to develop in complete absence of endogenous TGF-␤1 expression (13, 27) . However, there is increasing evidence that TGF-␤ might regulate the peripheral pool of CD4 ϩ
ϩ Treg. In vitro experiments with human naive T cells suggested that TGF-␤ may expand precommitted CD4 ϩ CD25 ϩ Treg (28). In vivo, it was shown that a transient pulse of TGF-␤ in the islets during the priming phase of diabetes protected mice from disease and increased the number of intraislet CD4 ϩ
ϩ T cells (29). TGF-␤ was shown to convert naive CD4
ϩ CD25 Ϫ responder T cells to CD4 ϩ CD25 ϩ T cells in the presence of TCR stimulation (11, 12) . We here describe a reduction in the numbers of peripheral CD4 
ϩ Treg in the setting of inflammation. No difference in the proliferative capacity of TG and WT Treg was observed in vitro or in vivo upon transfer into immunocompetent healthy and immunodeficient SCID mice. This indicates that TGF-␤ signaling alone is not sufficient to induce proliferation in Treg and that in vivo factors induced by inflammation might cooperate with TGF-␤ to induce proliferation.
In conclusion, we demonstrate here for the first time, that the effect of endogenous TGF-␤ on Treg themselves is required for their proper in vivo expansion and in vivo suppressive capacity. 
